Sémaglutide

Sémaglutide

Nom du produit Sémaglutide
Numéro CAS 910463-68-2
Formule moléculaire C187H291N45O59
Poids moléculaire 4113.58
Apparence Poudre blanche à blanc cassé
Pureté (HPLC) ≥98%
Colis 5g, 10g, 50g per container

Besoin d'aide ? Contacter notre équipe

Semaglutide Structure

Synonyms: Semaglutide, 910463-68-2, GLP-1 receptor agonist, GLP-1 analog, Semaglutide (USAN), Ozempic, Wegovy

Semaglutide is a synthetic analog of the human glucagon-like peptide-1 (GLP-1), a key incretin hormone that regulates glucose metabolism and appetite. It is a 31-amino acid peptide with a fatty acid side chain that enables extended half-life and once-weekly dosing. Developed for the treatment of type 2 diabetes and obesity, semaglutide has become a benchmark in the growing class of GLP-1 receptor agonists.

The molecule was engineered by substituting specific amino acids and attaching a C18 fatty diacid via a hydrophilic spacer, which promotes strong binding to albumin and slows renal clearance. This structural design allows for maintaining therapeutic concentrations over a week, a significant improvement over earlier GLP-1 analogs that required daily injections. Semaglutide is also being investigated for cardiovascular benefits and non-alcoholic steatohepatitis (NASH), reflecting its expanding clinical relevance.

As a research-grade peptide, semaglutide is supplied for laboratory use, including preclinical studies, analytical method development, and formulation research. It is typically offered as a lyophilized powder with a purity of at least 98% by HPLC, ensuring reliable performance in a range of experimental settings.

Fonction

  • GLP-1 receptor activation: Stimulates insulin secretion in a glucose-dependent manner.
  • Appetite regulation: Reduces food intake and promotes satiety.
  • Beta-cell protection: Supports pancreatic beta-cell function.
  • Cardiovascular benefits: May lower risk of major adverse cardiovascular events.

Source & Standardization

  • Source: Synthetic peptide, manufactured via solid-phase peptide synthesis.
  • Extraction: Not applicable; produced by chemical synthesis.
  • Normalisation: Purity ≥98% by HPLC; identity confirmed by mass spectrometry.
  • Formulaires: Lyophilized powder (as acetate or TFA salt).
  • Applications: Research use only; not for human or veterinary use.

Caractéristiques techniques

Paramètre Spécifications
Essai (HPLC) ≥98,01 TP3T
Apparence Poudre blanche à blanc cassé
Teneur en eau (KF) ≤8.0%
Acetate Content (if applicable) 5.0–12.0%
Endotoxin Level ≤5 EU/mg

Documentation et approvisionnement

  • Capacité mensuelle: 5 kg
  • Délai de livraison: 5–10 working days after order confirmation
  • Documentation: certificat d'analyse (COA), fiche de données de sécurité (FDS), fiche technique (TDS)
  • Emballage: Double polyethylene bags inside aluminum foil bag; custom packaging available

Demande de devis

  • Notre adresse: 280, rue Main, Xi'an, Shaanxi, Chine
  • LyvBio Co. — E-mail : info@lyvbio.com

RESTEZ EN CONTACT

Demande de devis

Notre adresse

280 Main Street, Xian, Shaanxi, Chine

×